The anhedonias: Clinical and neurobiological aspects

References

• Ribot T. The Psychology of Emotions. W. Scott, London 1897
   Google Scholar
• Berrios G E, Olivares J M. The anhedonias: a conceptual history. Hist Psychiatry 1995; 6: 453–70
   PubMedGoogle Scholar
• Olivares J M. Análisis histórico del concepto de anhedonia. Acta Psiquiatr Psicol Am Lat 1995; 41: 148–61
   PubMedGoogle Scholar
• Olivares J M. Anhedonía: una revisión conceptual. Rev Asoc Espoñ Neuropsiquiatria 1995; 52: 9–24
   Google Scholar
• Olivares J M. Aspectos clinicos y neurobiológicos de la anhedonia. Psiquis 1995; 16: 32–40
   Google Scholar
• Olivares J M. La formación del síntoma anhedonia. Maristán 1995; IV: 25–31
   Google Scholar
• Clouston T S. Clinical lectures in mental diseases. Churchill, London. 1887; 37
   Google Scholar
• Snaith P. Anhedonia: a neglected symptom of psychopathology. Psychol Med 1993; 23: 957–66
   PubMed Web of Science ®Google Scholar
• Cohen R. Das Anhedonie-Konzept in der Schizophrenie-Forschung. Nervenarzt 1989; 60: 313–7
   PubMedGoogle Scholar
• Loas G, Pierson A. L'anhedonie en psychiatrie: revue. Ann. Méd-psychol 1989; 147: 705–17
   Google Scholar
• American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders(3rd edn). APA, Washington DC. 1980
   Google Scholar
• World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders. WHO, Geneva 1992
   Google Scholar
• Rado S. Psychoanalysis of behaviour: Collected papers. Grime & Stratum, New York. 1956; (2 vols)
   Google Scholar
• Rado S, Daniels G. Changing concepts of psychoanalytic medicine. Grune & Stratton, New York. 1956
   Google Scholar
• Rado S. Theory and therapy: The theory of schizotypal organization and its application to the treatment of descompensated schizotypal behaviour. The outpatient treatment of schizophrenia, S C Scher, H R Davis. Grune & Stratton, New York. 1960
   Google Scholar
• Meehl P E. Schizotaxia, schizotypia, schizophrenia. Am Psychol 1962; 17: 827–38
   Web of Science ®Google Scholar
• Meehl P E. Genes and the unchangeable core. Voices 1974; 10: 25–35
   Google Scholar
• Meehl P E. Anger, anhedonia and the borderline syndrome. Am J Psychoanal 1975; 35: 157–61
   PubMedGoogle Scholar
• Meehl P E. “Hedonic capacity” ten years later: some clasifications. Anhedonia and affect deficit states, D C Clark, J Fawcett. PMA Publishing, New York 1987
   Google Scholar
• Klein D F. Endogenomorphic depression. A conceptual and terminological revision. Arch Gen Psychiatry 1974; 31: 447–54
   PubMed Web of Science ®Google Scholar
• Klein D F, Gittelman R, Quitkin F, et al. Diagnosis and drug treatment of psychiatric disorder: Adults and children. Williams & Wilkins, Baltimore 1980
   Google Scholar
• Klein D F. Depression and anhedonia. Anhedonia and ajffect deficit states, D C Clark, J Fawcett. PMA Publishing, New York. 1987
   Google Scholar
• Watson C G, Klett W G, Lorei T W. Toward an operational definition of anhedonia. Psychol Rep 1970; 26: 371–6
   PubMedGoogle Scholar
• Watson C G. Relationships of anhedonia to physiological reactivity and threshold. Psychol Rep 1972; 31: 43–6
   PubMedGoogle Scholar
• Watson C G. Relationships of anhedonia to learning under various contingencies. J Abnorm Psychol 1972; 80: 43–8
   PubMedGoogle Scholar
• Watson C G. Anhedonia as a function of non-affective interpretation of ambiguous stimuli and threshold for affective and neutral stimuli. J Clin Psychol 1977; 33: 58–63
   PubMedGoogle Scholar
• Watson C G, Jacobs L. Evidence for a dual-factor concept of psychopathological emotional deficit: anhedonia and sensation-seeking. J Clin Psychol 1977; 33: 385–9
   PubMedGoogle Scholar
• Watson C G, Anderson R, Schulte D. Responses of high-and low-emotional deficit patients to exciting, grating, and neutral stimuli. J Clin Psychol 1977; 33: 552–4
   PubMedGoogle Scholar
• Watson C G, Jacobs L. The relationships of anhedonia to pain adaptation and emotional deficit. J Clin Psychol 1977; 33: 555–7
   PubMedGoogle Scholar
• Watson C G, Kucala T, Jacobs L. The prediction of outcome from anhedonia and process-reactive scales. J Clin Psychol 1978; 34: 889–92
   PubMedGoogle Scholar
• Watson C G, Kucala T. Anhedonia and death. Psychol Rep 1978; 43: 1120–2
   PubMedGoogle Scholar
• Clark L E, Watson D. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100: 316–36
   PubMed Web of Science ®Google Scholar
• Harrow M, Grinker R R, Sr, Holzman P S, Kayton L. Anhedonia and schizophrenia. Am J Psychiatry 1977; 134: 794–7
   PubMedGoogle Scholar
• Chapman L J, Chapman J P, Raulin M L. Scales for physical and social anhedonia. J Abnorm Psychol 1976; 85: 374–82
   PubMed Web of Science ®Google Scholar
• Chapman L J, Chapman J P, Raulin M L. Body-image aberration in schizophrenia. J Abnorm Psychol 1978; 87: 399–407
   PubMed Web of Science ®Google Scholar
• Edell W S, Chapman L J. Anhedonia, perceptual aberration, and the Rorschach. J Consult Clin Psychol 1979; 47: 377–84
   PubMed Web of Science ®Google Scholar
• Penk W E, Carpenter J C, Rylee K E. MMPI correlates of social and physical anhedonia. J Consult Clin Psychol 1979; 47: 1046–52
   PubMed Web of Science ®Google Scholar
• Grove W M. Psychometric detection of schizotypy. Psychol Bull 1982; 92: 27–38
   PubMedGoogle Scholar
• Lenzenweger M F, Loranger A W. Psychosis proneness and clinical psychopathology: Examination of the correlates of schizotypy. J Abnorm Psychol 1989; 98: 3–8
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Buchanan R W. Anhedonia and the deficit syndrome of schizophrenia. Psych Res 1989; 31: 25–30
   Google Scholar
• Clementz B A, Grove W M, Katsanis J, Lacono W G. Psychometric detection of schizotypy: Perceptual aberration and physical anhedonia in relatives of schizophrenics. J Abnorm Psychol 1991; 100: 607–12
   PubMed Web of Science ®Google Scholar
• Katsanis J, Lacono W G, Beiser M. Anhedonia and perceptual aberration in first-episode psychotic patients and their relatives. J Abnorm Psychol 1990; 99: 202–6
   PubMed Web of Science ®Google Scholar
• Chapman L J, Chapman J P, Raulin M L, Edell W S. Schizotypy and thought disorder as a high risk approach to schizophrenia. Cognitive defects in the development of mental illness, G Serban. Brunner-Mazel, New York. 1978
   Google Scholar
• Schuck J, Leventhal D, Rothstein H, Irizarry V. Physical anhedonia and schizophrenia. J Abnorm Psychol 1984; 93: 342–4
   PubMedGoogle Scholar
• Katsanis J, Lacono W G, Beiser M, Lacey L. Clinical correlates of anhedonia and perceptual aberration in first-episode patients with schizophrenia and affective disorder. J Abnorm Psychol 1992; 101: 184–91
   PubMed Web of Science ®Google Scholar
• Garnet K E, Glick M, Edell W S. Anhedonia and premorbid competence in young, nonpsychoac psychiatric inpatients. J Abnorm Psychol 1993; 102: 580–3
   PubMedGoogle Scholar
• Eckblad M, Chapman L J, Chapman J P, Mishlove M. The Revised Social Anhedonia Scale. University of Wisconsin, Madison, WL 1982
   Google Scholar
• Mishlove M, Chapman L J. Social anhedonia in the prediction of psychosis proneness. J Abnorm Psychol 1985; 94: 384–96
   PubMed Web of Science ®Google Scholar
• Haberman M C, Chapman L J, Numbers J S, McFall R M. Relation of social competence to scores on two scales of psychosis proneness. J Abnorm Psychol 1979; 88: 675–7
   PubMedGoogle Scholar
• Erlenmeyer-Kimling L, Comblatt B A, Rock D, et al. The New York high-risk project: Anhedonia, attentional deviance, and psychopathology. Schizophr Bull 1993; 19: 141–53
   PubMed Web of Science ®Google Scholar
• Merrit R D, Balogh D W, DeVinney S E. Use of the MMPI to assess the construct validity of the Revised Social Anhedonia Scale as an index of schizotypy. J Personal Assess 1993; 60: 227–38
   PubMedGoogle Scholar
• Thaker G, Moran M, Adami H, Cassady S. Psychosis proneness scales in schizophrenia spectrum personality disorders: familial vs. nonfamilial samples. Psychiatry Res 1993; 46: 47–57
   PubMedGoogle Scholar
• Cook M, Simukonda F. Anhedonia and schizophrenia. Br J Psychiatry 1981; 139: 523–5
   PubMedGoogle Scholar
• Koh S D, Kayton L, Schwartz C. The structure of word storage in the permanent memory of nonpsychotic schizophrenics. J Consult Clin Psychol 1974; 42: 879–87
   PubMedGoogle Scholar
• Kayton L, Koh S D. Hypohedonia in schizophrenia. J Nerv Ment Dis 1975; 161: 412–9
   PubMedGoogle Scholar
• Koh S D, Kayton L, Peterson R A. Affective encoding and consequent remembering in schizophrenic young adults. J Abnorm Psychol 1976; 85: 156–66
   PubMed Web of Science ®Google Scholar
• Koh S D, Grinker R R, Sr, Marusarz T Z, Forman P L. Affective memory and schizophrenic anhedonia. Schizophr Bull 1981; 7: 292–307
   PubMed Web of Science ®Google Scholar
• Jones I H, Pansa-Henderson M. The relationship between nonverbal behavior and mental state symptoms in schizophrenic, depressed and anxiety neurosis patients. J Psych Treat Eval 1982; 4: 253–6
   Google Scholar
• Martin C C, Borod J C, Alpert M, et al. Spontaneous expression of facial emotion in schizophrenic and braindamaged patients. J Commun Disord 1990; 23: 287–301
   PubMed Web of Science ®Google Scholar
• Miller R E. Method to study anhedonia in hospitalized psychiatric patients. J Abnorm Psychol 1987; 94: 384–96
   Google Scholar
• Gottheil E, Paredes A, Exline R V, Winkelmayer R. Communication of affect in schizophrenia. Arch Gen Psychiatry 1970; 22: 439–44
   PubMed Web of Science ®Google Scholar
• Wittman M P. A scale for measuring prognosis in schizophrenic patients. Elgin State Hospital Papers 1941; 4: 20–33
   Google Scholar
• Watson C G, Jacobs L, Kucala T. A note on the pathology of anhedonia. J Clin Psychol 1979; 35: 740–3
   PubMedGoogle Scholar
• Liddle P F, Barnes T RE. The subjective experience of deficits in schizophrenia. Comprehen Psychiatry 1988; 29: 157–64
   PubMed Web of Science ®Google Scholar
• Loas G, Noisette C, Legrand A, et al. Clinical characteristics of chronic schizophrenic patients presenting with severe anhedonia. Encephale 1996; 22: 351–8
   PubMedGoogle Scholar
• Loas G, Noisette C, Legrand A, Boyer P. Anhedonia, depression and the deficit syndrome of schizophrenia. Acta Psychiatr Scand 1996; 94: 477–9
   PubMedGoogle Scholar
• Grinker R R, Holzman P S. Schizophrenic pathology in young adults: A clinical study. Arch Gen Psychiatry 1973; 28: 168–75
   PubMedGoogle Scholar
• Silverstone P H. Is anhedonia a good measure of depression?. Acta Psychiatr Scand 1991; 83: 249–50
   PubMedGoogle Scholar
• Cutting J. The right cerebral hemisphere and psychiatric disorders. Oxford University Press, New York. 1990
   Google Scholar
• Lutzenberger W, Birbaumer N, Rockstroh B, Elbert T. Evaluation of contingencies and conditional probabilities. Archiv Psych Nervenkr 1983; 233: 471–88
   PubMedGoogle Scholar
• Piersoh A, Ragot R, Ripoche A, Lesevre N. Electro-physiological changes elicited by auditory stimuli given a positive or negative value: a study comparing anhedonic with hedonic subjects. Int J Psychophysiol 1987; 5: 107–23
   PubMedGoogle Scholar
• Pierson A, Loas G, Lesevre N. Etude de potentiels évoqués cognitifs en function de la valence affective et de la signification des stimulus chez des sujets anhédoniques avec attitudes dysfonctionnelles. L'Encéphale 1990; 16: 209–16
   PubMedGoogle Scholar
• Loas G, Salinas E, Guelfi J D, Samuel-Lajeneusse B. Physical anhedonia in major depressive disorder. J Affect Dis 1992; 25: 139–46
   PubMedGoogle Scholar
• Loas G, Pierson A. L'anhédonie en psychiatric: revue. Ann Méd-psychol 1989; 147: 705–17
   PubMedGoogle Scholar
• Loas G, Boyer P. Anhedonia in psychotic and non-psychotic disorders. Clin Neuropharmacol 1992; 15: 558A–559A
   Google Scholar
• Loas G. Anhedonia in major depression. Comparison of 55 depressed patients with 54 healthy probands. Encéphale 1995; 21: 559–62
   PubMedGoogle Scholar
• Loas G, Fremaux D, Gayant C, Boyer P. Physical anhedonia and depression: distinct concepts? Study of the construct validity of these dimensions in a group of 224 normal subjects. Encéphale 1996; 22: 175–9
   PubMedGoogle Scholar
• Fawcett J, Clark D C, Scheftner W A, Gibbons R D. Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry 1983; 40: 79–84
   PubMed Web of Science ®Google Scholar
• Clark D C, Fawcett J. Anhedonia, hypohedonia and pleasure capacity in major depressive disorders. Anhedonia and affect deficit states, D C Clark, J Fawcett. PMA Publishing, New York. 1987
   Google Scholar
• Fawcett J, Clark D C, Scheftner W A, Hedeker D. Differences between anhedonic and normally hedonic depressive states. Am J Psychiatry 1983; 140: 1027–30
   PubMedGoogle Scholar
• Davidson J, Turnbull C, Strickland R, Belyea M. Comparative diagnostic criteria for melancholia and endogenous depression. Arch Gen Psychiatry 1984; 41: 506–11
   PubMedGoogle Scholar
• Zimmerman M, Black D W, Coryel W. Diagnostic criteria for melancholia: the comparative validity of DSM-III and DSM-III-R. Arch Gen Psychiatry 1989; 46: 361–8
   PubMed Web of Science ®Google Scholar
• Hardy P, Jouvent R, Lancrenou S, et al. L'échelle de plaisir-déplaisir: utilisation dans l'évaluation de la maladie depressive. Encéphale 1986; 12: 149–54
   PubMedGoogle Scholar
• Loas G, Salinas E, Pierson A, et al. Anhedonia and blunted affect in major depressive disorder. Comprehen Psychiatry 1994; 35: 366–72
   PubMedGoogle Scholar
• Brown S L, Sweeney D R, Schwartz G E. Differences between self-reported and observed pleasure in depression and schizophrenia. J Nerv Merit Dis 1979; 167: 410–5
   PubMedGoogle Scholar
• Berembaum H, Snowhite R, Oltmanns T F. Anhedonia and emotional responses to affect evoking stimuli. Psychol Med 1987; 17: 677–84
   PubMedGoogle Scholar
• Simons R F, Russo K R. Event-related potentials and continuous performance in subjects with physical anhedonia or perceptual aberrations. J Psychophysiol 1987; 1: 401–10
   Google Scholar
• Miller G A. Information processing deficits in anhedonia and perceptual aberration: a psychophysiological analysis. Biol Psychiatry 1986; 21: 100–15
   PubMedGoogle Scholar
• Pierson A, Loas G, Lesevre N. Etude de potentiels évoqués cognitifs en fonction de la valence affective et de la signification des stimulus chez des sujets anhédoniques avec attitudes dysfonctionnelles. L'Encéphale 1990; 16: 209–16
   PubMedGoogle Scholar
• Fitzgibbons L, Simons R F. Affective response to color-slide stimuli in subjects with physical anhedonia: A three-systems analysis. Psychophysiology 1992; 29: 613–20
   PubMed Web of Science ®Google Scholar
• Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 1954; 47: 419–27
   PubMed Web of Science ®Google Scholar
• Heath R G. Application of Sandor Rado's adaptational psychodynamic formulations to brain physiology. J Am Acad Psychoanal 1974; 2: 19–25
   Google Scholar
• Stein L, Wise C D. Possible aetiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 1971; 171: 1032–6
   PubMed Web of Science ®Google Scholar
• Wise C D, Stein L. Dopamine-β-hydroxylase deficits in the brains of schizophrenic patients. Science 1973; 181: 344–7
   PubMed Web of Science ®Google Scholar
• Wise R A, Spindler J, De Wit H, Gerber G J. Neuroleptic-induced “anhedonia” in rats: Pimozide blocks reward quality of food. Science 1978; 201: 262–4
   PubMed Web of Science ®Google Scholar
• Olds J, Killiam K F, Bach Y, Rita P. Self-stimulation of the brain used as a screening method for tranquilizing drugs. Science 1956; 124: 265–6
   PubMedGoogle Scholar
• Dews P B, Morse W H. Behavioural pharmacology. Ann Rev Pharmachol 1961; 1: 145–74
   Google Scholar
• Gray T, Wise R A. Effects of pimozide on lever-pressing behavior maintained on an intermittent reinforcement schedule. Pharmacol Biochem Behav 1980; 12: 931–5
   PubMed Web of Science ®Google Scholar
• Wise R A. Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 1982; 5: 39–87
   Web of Science ®Google Scholar
• Evans K R, Eikelboom R. Feeding induced by ventricular bromocriptine and amphetamine: a possible excitatory role for dopamine in eating behavior. Behav Neurosci 1987; 101: 591–3
   PubMedGoogle Scholar
• Asin K E, Wirtshafter D. Evidence for dopamine involvement in reinforcement obtained using a latent extinction paradigm. Pharmacol Biochem Behav 1990; 36: 417–20
   PubMedGoogle Scholar
• Leeb K, Parker L, Eikelboom R. Effects of pimozide on the hedonic properties of sucrose: Analysis by the taste reactivity test. Pharmacol Biochem Behav 1991; 39: 895–901
   PubMed Web of Science ®Google Scholar
• Wirtshafter D, Asin K E. Dissociation of haloperidol-induced ‘anhedonia’ and catalepsy by lesions of the dorsal raphe nucleus. Pharmacol Biochem Behav 1991; 40: 1001–4
   PubMedGoogle Scholar
• Crow T J. Molecular pathology of schizophrenia: More than one disease process. Br Med J 1980; 280: 66–8
   PubMed Web of Science ®Google Scholar
• Mackay A VP. Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1980; 137: 379–83
   PubMed Web of Science ®Google Scholar
• Andreasen N C, Olsen S. Negative vs. positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982; 39: 789–94
   PubMed Web of Science ®Google Scholar
• Carnoy P, Soubrie P, Puech A J, Simon P. Performance deficit induced by low doses of dopamine agonists in rats. Toward a model for approaching the neurobiology of negative schizophrenic symptomatology?. Biol Psychiatry 1986; 21: 11–22
   PubMedGoogle Scholar
• Ettenberg A, Koob G F, Bloom F E. Response artefact in the measurement of neuroleptic-induced anhedonia. Science 1981; 213: 357–9
   PubMedGoogle Scholar
• Faustman W O, Fowler S C. An examination of methodological refinements, clozapine and fluphenazine in the anhedonia paradigm. Pharmacol Biochem Behav 1982; 17: 987–93
   PubMedGoogle Scholar
• Morley M J, Bradshaw C M, Szabadi E. The effect of pimozide on variable-interval performance: a test of the ‘anhedonia’ hypothesis of the mode of action of neuroleptics. Psychopharmacol 1984; 84: 531–6
   Google Scholar
• Gramling S E, Fowler S C, Collins K R. Some effects of pimozide on nondeprived rats licking sucrose solutions in an anhedonia paradigm. Pharmacol Biochem Behav 1984; 21: 617–24
   PubMedGoogle Scholar
• Gramling S E, Fowler S C, Tizzano J. Some effects of pimozide on nondeprived rats' lever pressing maintained by a sucrose reward in an anhedonia paradigm. Pharmacol Biochem Behav 1987; 27: 67–72
   PubMedGoogle Scholar
• Ljungberg T. Blockade by neuroleptics of water intake and operant responding for water in the rat: Anhedonia, motor deficit, or both?. Pharmacol Biochem Behav 1987; 27: 341–50
   PubMedGoogle Scholar
• Ljungberg T. Scopolamine reverses haloperidol-attenuated lever-pressing for water but not haloperidol-attenuated water intake in the rat. Pharmacol Biochem Behav 1988; 29: 205–8
   PubMedGoogle Scholar
• Kirkpatrick M A, Fowler S C. Force-proportional reinforcement: Pimozide does not reduce rats' emission of higher forces for sweeter rewards. Pharmacol Biochem Behav 1989; 32: 499–504
   PubMedGoogle Scholar
• Acquas E, Carboni E, Leone P, Di Chiara G. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?. Psychopharmacol 1989; 99: 151–5
   Google Scholar
• King D J. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990; 157: 799–811
   PubMed Web of Science ®Google Scholar
• King D J, Henry G. The effect of neuroleptics on cognitive and psychomotor function. A preliminary study in healthy volunteers. Br J Psychiatry 1992; 160: 647–53
   PubMed Web of Science ®Google Scholar
• Pagan D, Scott D B, Mitchell M, Tiplady B. Effects of remoxipride on measures of psychological performance in healthy volunteers. Psychopharmachology 1991; Berl 105: 225–9
   PubMedGoogle Scholar
• Danion J M, Peretti S, Grange D, et al. Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers. Psychopharmacology 1992; Berl 108: 345–51
   PubMedGoogle Scholar
• Rosellini R A. Inescapable shock interferes with the acquisition of a free appetitive operant. Anim Learn Behav 1978; 6: 155–9
   Google Scholar
• Rosellini R A, De Cola J P. Inescapable shock interferes with the acquisition of a low-activity response in an appetitive context. Anim Learn Behav 1981; 9: 487–90
   Google Scholar
• Katz R, Roth K, Carroll B. Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression. Neurosci Biobehav Rev 1981; 5: 247–51
   PubMed Web of Science ®Google Scholar
• Katz R. Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav 1982; 16: 965–8
   PubMed Web of Science ®Google Scholar
• Zacharko R M, Bowers W J, Kokkinidis L, Anisman H. Region specific reductions of intracranial self-stimulation after uncontrollable stress: Possible effects on reward processes. Behav Brain Res 1983; 9: 129–41
   PubMed Web of Science ®Google Scholar
• Zacharko R M, Bowers W J, Anisman H. Responding for brain stimulation: stress and desmethylimipramine. Prog Neuropsychopharmacol 1984; 8: 601–6
   Google Scholar
• Zacharko R M, Bowers W J, Kelley M S, Anisman H. Prevention of stress-induced disturbances of self-stimulation by desmethylimipramine. Brain Res 1984; 321: 175–9
   PubMedGoogle Scholar
• Zacharko R M, Gilmore W, MacNeil G, et al. Stressor induced variations of intracranial self-stimulation from the mesocortex in several strains of mice. Brain Res 1990; 533: 353–7
   PubMedGoogle Scholar
• Zacharko R M, Kasian M, MacNeil G, Anisman H. Stressor-induced behavioral alterations in intracranial self-stimulation from the ventral tegmental area: evidence for regional variations. Brain Res Bull 1990; 25: 617–21
   PubMedGoogle Scholar
• Zacharko R M, Anisman H. Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci Biobehav Rev 1991; 15: 391–405
   PubMed Web of Science ®Google Scholar
• Muscat R, Willner P. Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev 1992; 16: 507–17
   PubMedGoogle Scholar
• Willner P, Golembiowska K, Klimek V, Muscat R. Reduction of sucrose preference by chronic unpredictable stress, and its restoration by a tricyclic antidepressant. Psychopharmacol 1990; 93: 358–64
   Google Scholar
• Muscat R, Towell A, Willner P. Changes in dopamine autoreceptor sensitivity in an animal model of depression. Psychopharmacol 1987; 94: 545–50
   Google Scholar
• Plasnik A, Stefanski R, Kostowski W. Restraint stress-induced changes in saccharin preference: the effect of antidepressive treatment and diazepam. Pharmacol Biochem Behav 1989; 33: 755–9
   PubMedGoogle Scholar
• Papp M, Willner P, Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable stress. Psychopharmacol 1991; 104: 255–9
   PubMed Web of Science ®Google Scholar
• Muscat R, Willner P. Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev 1992; 16: 507–17
   PubMedGoogle Scholar
• Moureau J L, Jenck F, Martin J R, et al. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol 1992; 2: 43–9
   PubMedGoogle Scholar
• Haefely W, Burkard W P, Cesura A, et al. Pharmacology of moclobemide. Clin Neuropharmacol 1993; 16: S8–S18
   Google Scholar
• Moureau J L, Jenck F, Martin J R, et al. Effects of moclobemide, a new generation reversible Mao-A inhibitor, in a novel animal model of depression. Pharmacopsychiatria 1993; 26: 30–3
   Google Scholar
• Papp M, Wilner P, Muscat R. Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. Psychopharmacol 1993; 110: 159–64
   Web of Science ®Google Scholar
• Papp M, Moryl E. New evidence for the antidepressant activity of MK-801, a non-competitive antagonist of NMDA receptors. Pol J Pharmacol 1993; 45: 549–53
   PubMedGoogle Scholar
• Moureau J L, Bourson A, Jenck F, et al. Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression. J Psych Neurosci 1994; 19: 51–6
   PubMedGoogle Scholar
• Moureau J L, Jenck F, Martin J R, et al. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol 1992; 2: 43–9
   PubMedGoogle Scholar
• Stamford J A, Muscat R, O'Connor J J, et al. Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine. Psychopharmacol 1991; 105: 275–82
   Google Scholar
• Dess N K, Choe S. Stress selectively reduces sugar + saccharin mixture intake but increases proportion of calories consumed as sugar by rats. Psychobiol 1994; 22: 77–84
   Google Scholar
• Markou A, Koob G F. Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacol 1991; 4: 17–26
   PubMed Web of Science ®Google Scholar
• Gawin F H, Kleber H D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 1986; 43: 107–13
   PubMed Web of Science ®Google Scholar
• Gawin F H. Chronic neuropharmacology of cocaine: Progress in pharmacotheraphy. J Clin Psychiatry 1988; 49: 11–16
   PubMed Web of Science ®Google Scholar
• Koob G F, Goeders N E. Neuroanatomical substrates of drug self-administration. The neuropharmacological basis of reward, J M Liebman, S J Cooper. Oxford University Press, New York 1989
   Google Scholar
• Koob G F. Neural mechanisms of drug reinforcement. Ann N York Acad Sci 1992; 654: 171–91
   PubMed Web of Science ®Google Scholar
• Markou A, Koob G F. Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacol 1992; 7: 213–24
   PubMedGoogle Scholar
• Weiss F, Hurd Y L, Ungerstedt U, et al. Neurochemical correlates of cocaine and ethanol self-administration. Ann NY Acad Sci 1992; 654: 220–41
   PubMedGoogle Scholar
• Weiss F, Markou A, Lorang M T, Koob G F. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 1992; 539: 314–8
   Google Scholar
• Pulvirenti L, Koob G F. Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats. Neuropsychopharmacol 1993; 8: 213–8
   PubMedGoogle Scholar
• Cummings J L. The neuroanatomy of depression. J Clin Psychiatry 1993; 54: 14–20
   PubMed Web of Science ®Google Scholar
• Maddeaux C, Zacharko R M. Intraventricular administration of D-ala2-met5-enkephalinamide induces rapid recovery of responding for electrical brain stimulation from the ventral tegmental area following uncontrollable foot-shock. Brain Res Bull 1992; 28: 337–41
   PubMedGoogle Scholar
• Wise R A, Bozarth M A. Brain substrates for reinforcement and drug self-administration. Prog Neuro-Psychopharmacol 1981; 5: 467–74
   Google Scholar
• Wise R A, Bozarth M A. Actions of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol Biochem Behav 1982; 17: 239–43
   PubMed Web of Science ®Google Scholar
• Wise R A. Actions of drugs of abuse on brain reward systems. Pharmacol Biochem Behav 1980; 13: 213–23
   PubMed Web of Science ®Google Scholar
• Collier T J. The role of brain opioid systems. Anhedonia and affective deficit states, D C Clark, J Fawcett. PMA Publishing, New York 1987
   Google Scholar
• Crow T J. Catecholamine-containing neurones and electrical self-stimulation: 2. A theoretical interpretation and some psychiatric implications. Psychol Med 1973; 3: 66–73
   PubMedGoogle Scholar
• Crow T J. A general catecholamine hypothesis. Neurosci Res Prog Bull 1977; 15: 195–205
   Google Scholar
• Franklin K BJ. Catecholamines and self-stimulation reward and performance effects dissociated. Pharmacol 1978; Biochem Behav 9: 813–20
   Google Scholar
• Hunt G E, Atrens D M, Chesner G B. α-noradrenergic modulation of hypothalamic self-stimulation: Studies employing clonidine, 1-phenylephrine and α-methyl-b-tyrosine. Eur J Pharmacol 1976; 37: 105–11
   PubMedGoogle Scholar
• Van Praag H M, Asnis G M, Kahn R S, et al. Monoamines and abnormal behaviour. A multi-aminergic perspective. Br J Psychiatry 1990; 157: 723–34
   PubMed Web of Science ®Google Scholar
• Dworkin R H, Saczynski K. Individual differences in hedonic capacity. J Personal Assess 1984; 48: 620–6
   PubMed Web of Science ®Google Scholar
• Berembaum H, Oltmanns T F, Gottesman I I. Hedonic capacity in schizophrenics and their twins. Psychol Med 1990; 20: 367–74
   PubMedGoogle Scholar
• Berembaum H, McGrew J. Familial resemblance of schizotypic traits. Psychol Med 1993; 23: 327–33
   PubMedGoogle Scholar
• Berrios G E, Markova I S, Olivares J M. Sintomas mentales: Hacia una nueva meta-teoria. Psiquiatrta Biol 1995; 2: 51–62
   Google Scholar
• Shoichet R P, Oakley A. Notes on the treatment of anhedonia. Can. Psychiatr Assoc J 1978; 23: 487–492
   PubMedGoogle Scholar
• Watson C G, Jacobs L. Interrelationships and correlates of four measures of pleasure deficit. J Clin Psychol 1980; 36: 142–147
   PubMedGoogle Scholar
• Chapman L J, Edell W S, Chapman J P. Physical anhedonia, perceptual aberration, and psychosis proneness. Schizophr Bull 1980; 6: 639–653
   PubMed Web of Science ®Google Scholar
• Numbers J S, Chapman L J. Social deficits in hypothetically psychosis-prone college women. J Abnorm Psychol 1982; 91: 255–260
   PubMedGoogle Scholar
• Peterson C A, Knudson R M. Anhedonia: A construct validation approach. J Person Assess 1983; 47: 539–551
   PubMed Web of Science ®Google Scholar
• Simons R F. Electrodermal and cardiac orienting in psychometrically defined high-risk subjects. Psychiatry Res 1981; 4: 347–356
   PubMedGoogle Scholar
• Lutzenberger W, Elbert T, Rockstroh B, Birbaumer N, Stegagno I. Slow cortical potentials in subjects with high or low scores on a questionnaire measuring physical anhedonia and body image distortion. Psychophysiology 1981; 18(4)371–380
   PubMedGoogle Scholar
• Simons R F. Physical anhedonia and future psycho-pathology: An electrocortical continuity?. Psychophysiol 1982; 19: 433–441
   PubMedGoogle Scholar
• Simons R F, McMillan F W, III, Ireland F B. Anticipatory pleasure deficit in subjects reporting physical anhedonia: Slow cortical evidence. Biol Psychol 1982b; 14: 297–310
   Google Scholar
• Simons R F, McMillan F W, III, Ireland F B. Reaction-time cross-over in preselected schizotypic subjects. J Abnorm Psychol 1982a; 91: 414–419
   PubMedGoogle Scholar
• Miller G A, Simons R F, Lang P J. Electrocortical measures of information processing deficit in anhedonia. Ann New York Acad Sci 1984; 425: 598–602
   PubMedGoogle Scholar
• Simons R F, Russo K R. Event-related potentials and continuous performance in subjects with physical anhedonia or perceptual aberrations. J Psychophysiol 1987; 1: 401–410
   Google Scholar
• Bernstein A S, Riedel J A. Psychophysiological response patterns in college students with high physical anhedonia: scores appear to reflect schizotypy rather than depression. Biol Psychiatry 1987; 22: 829–847
   PubMed Web of Science ®Google Scholar
• Pierson A, Ragot R, Ripoche A, Lesevre N. Modifications d'indices d'activation varies en fonction de la valence acquise par un stimulus chez des sujets anhedoniques et depressogenes. Neurophysiol Clin 1988; 18: 33–49
   PubMedGoogle Scholar
• Drewer H, Shean G D. Reaction time crossover in schizotypal subjects. J Nerv Ment Dis 1993; 181: 27–30
   PubMedGoogle Scholar